Elisabeth Leiderman is the Chief Financial Officer and Chief Business Officer of Atsena Therapeutics. She previously worked at Decibel Therapeutics as a Chief Financial Officer & Head of Corporate Development. Elisabeth Leiderman attended The Wharton School.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Bluebird Bio | Board of Directors and Audit Committee Chair | Oct 1, 2021 | — | Detail |